Evidence map›Paper›PMID 24236211›Full record

ArticlePloS one2013

Increased cell surface free thiols identify effector CD8+ T cells undergoing T cell receptor stimulation.

Samuel Troy Pellom, Ryan D Michalek, Katie E Crump, P Kent Langston, Daniel G Juneau, Jason M Grayson

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.3field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Human Serum Albumin-Delivered [Au(PEtACS medicinal chemistry letters · 2017
    Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Samuel Troy PellomLaboratory of Lymphocyte Function, Meharry Medical College, Nashville, Tennessee, United States of America.
Ryan D Michalek
Katie E Crump
P Kent Langston
Daniel G Juneau
Jason M Grayson
Wake Forest University · USMeharry Medical College · USMetabolon (United States) · US

Funding

TRAINING PROGRAM IN IMMUNOLOGY AND PATHOGENESIST32AI007401 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI Martha Ann Alexander-Miller · 1991 to 2026
$4.4M
Redox control of CD8 T cell proliferation, differentiation and deathR01AI068952 · NIAID · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI GRAYSON, JASON MITCHELL · 2008 to 2012
$1.6M
NIAID NIH HHS 5T32AI007401-20NIAID NIH HHS R01 AI068952NIAID NIH HHS R01-AI068952NIAID NIH HHS T32 AI007401
6 · The paper itself

Abstract

Recognition of peptide Major Histocompatibility Complexes (MHC) by the T cell receptor causes rapid production of reactive oxygen intermediates (ROI) in naïve CD8(+) T cells. Because ROI such as H2O2 are membrane permeable, mechanisms must exist to prevent overoxidation of surface proteins. In this study we used fluorescently labeled conjugates of maleimide to measure the level of cell surface free thiols (CSFT) during the development, activation and differentiation of CD8(+) T cells. We found that during development CSFT were higher on CD8 SP compared to CD4 SP or CD4CD8 DP T cells. After activation CSFT became elevated prior to division but once proliferation started levels continued to rise. During acute viral infection CSFT levels were elevated on antigen-specific effector cells compared to memory cells. Additionally, the CSFT level was always higher on antigen-specific CD8(+) T cells in lymphoid compared to nonlymphoid organs. During chronic viral infection, CSFT levels were elevated for extended periods on antigen-specific effector CD8(+) T cells. Finally, CSFT levels on effector CD8(+) T cells, regardless of infection, identified cells undergoing TCR stimulation. Taken together these data suggest that CD8(+) T cells upregulate CSFT following receptor ligation and ROI production during infection to prevent overoxidation of surface proteins.

Indexed as

AnimalsCD8-Positive T-LymphocytesCell MembraneFemaleImmunologic MemoryImmunophenotypingLymphocyte ActivationLymphocytic ChoriomeningitisLymphocytic choriomeningitis virusLymphoid TissueMiceMice, TransgenicPhenotypeReceptors, Antigen, T-CellSulfhydryl CompoundsReceptors, Antigen, T-CellSulfhydryl Compounds

Identifiers

PMID24236211
PMCPMC3827480
OpenAlexW2045788339

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.